We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Sen. Chuck Schumer is raising red flags about the shortage of GlaxoSmithKline’s ultrapopular Shingrix vaccine, blaming the government shutdown for making the situation worse.
Sen. Chuck Schumer is raising red flags about the shortage of GlaxoSmithKline’s ultrapopular Shingrix vaccine, blaming the government shutdown for making the situation worse.
Three years after closing a record-breaking $320m private financing Immunocore is having a personnel crisis. The shock departure in February of its chief executive, Eliot Forster, has had a contagious effect, with various other execs, including chief medi